je.st
news
Home
› Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO
Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO
2014-08-29 21:55:11| Chemicals - Topix.net
Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO to include additional high-risk patient populations.
Tags: research
program
global
explorer
Category:Chemicals